1 / 1

Age > 75 years, warfarin

Age > 75 years, warfarin. Stroke/SE on rivaroxaban or warfarin, in patients younger or older than 75 years old (ROCKET-AF). Age < 75 years, warfarin. Age > 75 years, rivaroxaban. Age < 75 years, rivaroxaban. Estimated cumulative probability of stroke/SE (%).

kathy
Télécharger la présentation

Age > 75 years, warfarin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Age > 75 years, warfarin Stroke/SE on rivaroxaban or warfarin, in patients younger or older than 75 years old (ROCKET-AF) Age < 75 years, warfarin Age > 75 years, rivaroxaban Age < 75 years, rivaroxaban Estimated cumulative probability of stroke/SE (%) HR (95%CI) Rivaroxaban vs. Warfarine Age > 75 years: 0.80 (0.63-1.02) Age < 75 years: 0.95 (0.76-1.19) Halperin JL et al., Circulation 2014

More Related